Theme

The Biotech Growth Trust

BIOGFinancial Services
1,116.00GBX
-1.24%
Market Cap
262.22M
Volume
20.3k
18% of avg
P/E Ratio
NaN
EPS (TTM)
Beta
0.34
Day Range
1,110.00p - 1,155.00p
52 Week Range
612.70p1,116.00p1,210.00p
1,116.00p

Upcoming Events

20 November 2025
Publication of half-year results
2026
Annual General Meeting
Mid 2028
Interim continuation vote
High Impact Event
BIOG
NEUTRAL

The Biotech Growth Trust PLC Confirms Compliance with Market Abuse Regulation

The investment trust confirms it has complied with market abuse regulations, providing no material updates on its financial position or outlook.

BIOG
NEUTRAL

The Biotech Growth Trust PLC Announces Director/PDMR Shareholding

The prominent investment trust has announced a change in its non-executive director's shareholding.

BIOG
NEUTRAL

The Biotech Growth Trust PLC Announces Investor Presentation

The prominent investment trust is hosting an investor presentation via Investor Meet Company.

BIOG
NEUTRAL

The Biotech Growth Trust PLC Publishes Monthly Fact Sheet

The asset management firm has released its monthly fact sheet, providing an update on the performance of its biotechnology-focused investment trust.

BIOG
BAD

The Biotech Growth Trust Provides Investor Webinar Update

The prominent biotech investment trust announces an investor webinar, but the tone of the update suggests the company is facing a challenging operating environment.

BIOG
BAD

The Biotech Growth Trust Appoints New Director with Public Health Expertise

The prominent biotech investment trust has appointed a new director with extensive public health leadership experience, as the company navigates the integration of multiple agencies into a unified health security organization.

BIOG
NEUTRAL

The Biotech Growth Trust PLC Publishes Monthly Fact Sheet

The prominent investment trust has released its monthly fact sheet, providing an update on its portfolio and activities.

BIOG
NEUTRAL

The Biotech Growth Trust PLC Announces Capital Reduction

The retailer has announced a capital reduction to provide more flexibility for future share buybacks or returns of capital.

BIOG
BAD

The Biotech Growth Trust PLC Faces Headwinds

The prominent investment trust is facing challenges, according to its latest update.

BIOG
NEUTRAL

The Biotech Growth Trust PLC Publishes Monthly Fact Sheet

The prominent investment trust has released its monthly fact sheet, providing an update on the company's status.